Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Knoll develops potential new antipsychotic agent with advantages over available therapies

Nov. 10, 1998

LEF-553: a potent mu-opioid receptor agonist with peripheral analgesic effects

Nov. 10, 1998

NK1 antagonist L-732138 exhibits activity indicating efficacy in neuropathic pain

Nov. 10, 1998

Novel sodium channel blocker from Roche evaluated in vitro for neuroprotective efficacy

Nov. 10, 1998

Reversible mixed MAO-A/MAO-B inhibitor discovered at Synthelabo is presented this week

Nov. 10, 1998

RPR-118723: a novel anticonvulsant and potent glycine-site NMDA receptor antagonist

Nov. 10, 1998

Pfizer presents preclinical profile of potent, full 5-HT1D receptor antagonist

Nov. 10, 1998

Pharmacia & Upjohn patents new agents for CNS and neurodegenerative disorders

Nov. 10, 1998

Noncytotoxic thiocolchicine derivatives useful as muscle relaxants

Nov. 10, 1998

Compounds acting on metabotropic glutamate receptors disclosed by Lilly

Nov. 10, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 20, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...
Regeneron’s fianlimab lags in melanoma, does $2.3B deal with Parabilis
BioWorld
Regeneron Pharmaceuticals Inc. stuck with the tradition of releasing bad news on Friday afternoon and good news on Monday morning with a pair of announcements...